Commercial Activist investor renews its criticism of Novavax PharmaphorumShah Capital has fired another broadside at vaccine firm Novavax, accusing its board and management of a "destruction in shareholder value."CommercialRead full story pharminent April 8, 2026 (Last updated: April 8, 2026) Pharmaphorum Shah Capital has fired another broadside at vaccine firm Novavax, accusing its board and management of a “destruction in shareholder value.” CommercialRead full story Post navigation Previous: Insmed Scraps Skin Plans for Lung Disease Drug as Competitors Make HeadwayNext: Sidewinder pockets $137m in Series B to take bispecific ADCs to clinic Related Stories Commercial Novo’s CEO champions “record-breaking start” for Wegovy pill in US market pharminent May 8, 2026 Commercial Novo hikes guidance on Wegovy pill’s fast sales start pharminent May 6, 2026 Commercial Novo’s Wegovy pill reaches 1M patients, shattering expectations with $355M in sales pharminent May 6, 2026
